These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35148936)

  • 41. Glucometabolic changes influence hospitalization and outcome in patients with COVID-19: An observational cohort study.
    Clausen CL; Leo-Hansen C; Faurholt-Jepsen D; Krogh-Madsen R; Ritz C; Kirk O; Jørgensen HL; Benfield T; Almdal TP; Snorgaard O
    Diabetes Res Clin Pract; 2022 May; 187():109880. PubMed ID: 35483546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperglycaemia increases mortality risk in non-diabetic patients with COVID-19 even more than in diabetic patients.
    Morse J; Gay W; Korwek KM; McLean LE; Poland RE; Guy J; Sands K; Perlin JB
    Endocrinol Diabetes Metab; 2021 Oct; 4(4):e00291. PubMed ID: 34505406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognosis of Ischemic Stroke With Newly Diagnosed Diabetes Mellitus According to Hemoglobin A1c Criteria in Chinese Population.
    Jing J; Pan Y; Zhao X; Zheng H; Jia Q; Li H; Guan L; Liu L; Wang C; Meng X; He Y; Wang Y; Wang Y
    Stroke; 2016 Aug; 47(8):2038-44. PubMed ID: 27382009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycemia, Beta-Cell Function and Sensitivity to Insulin in Mildly to Critically Ill Covid-19 Patients.
    Ilias I; Diamantopoulos A; Pratikaki M; Botoula E; Jahaj E; Athanasiou N; Tsipilis S; Zacharis A; Vassiliou AG; Vassiliadi DA; Kotanidou A; Tsagarakis S; Dimopoulou I
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33466617
    [No Abstract]   [Full Text] [Related]  

  • 47. The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19).
    Llauradó G; Vlacho B; Wargny M; Ruan Y; Franch-Nadal J; Domingo P; Gourdy P; Saulnier PJ; Hadjadj S; Wild SH; Rea R; Cariou B; Khunti K; Mauricio D;
    Cardiovasc Diabetol; 2022 Oct; 21(1):216. PubMed ID: 36261811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Newly Diagnosed Diabetes in Patients with COVID-19: Different Types and Short-Term Outcomes.
    Farag AA; Hassanin HM; Soliman HH; Sallam A; Sediq AM; Abd Elbaser ES; Elbanna K
    Trop Med Infect Dis; 2021 Aug; 6(3):. PubMed ID: 34449740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of secondary sepsis in COVID-19 mortality: Observations on patients with preexisting diabetes mellitus and newly diagnosed hyperglycemia.
    Nair AM; Gopalan S; Rajendran V; Varadaraj P; Marappa L; Pandurangan V; Madhavan S; Mani R; Bhaskar E
    Monaldi Arch Chest Dis; 2022 Apr; 92(4):. PubMed ID: 35416000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
    Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
    Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetes IN hospital - Glucose and Outcomes in the COVID-19 pandemic (DINGO COVID-19): the 2020 Melbourne hospital experience prior to novel variants and vaccinations.
    Barmanray RD; Gong JY; Kyi M; Kevat D; Islam MA; Galligan A; Manos GR; Nair IV; Perera N; Adams NK; Nursing A; Warren AM; Hamblin PS; MacIsaac RJ; Ekinci EI; Krishnamurthy B; Karunajeewa H; Buising K; Visvanathan K; Kay TWH; Fourlanos S
    Intern Med J; 2023 Jan; 53(1):27-36. PubMed ID: 36269315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of adverse in-hospital outcome and recovery in patients with diabetes mellitus and COVID-19 pneumonia in Iraq.
    Nafakhi H; Alareedh M; Al-Buthabhak K; Shaghee F; Nafakhi A; Kasim S
    Diabetes Metab Syndr; 2021; 15(1):33-38. PubMed ID: 33296788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes and stress hyperglycemia associated with myocardial infarctions at an urban municipal hospital: prevalence and effect on mortality.
    Nordin C; Amiruddin R; Rucker L; Choi J; Kohli A; Marantz PR
    Cardiol Rev; 2005; 13(5):223-30. PubMed ID: 16106183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stress-Induced Hyperglycemia in Diabetes: A Cross-Sectional Analysis to Explore the Definition Based on the Trauma Registry Data.
    Rau CS; Wu SC; Chen YC; Chien PC; Hsieh HY; Kuo PJ; Hsieh CH
    Int J Environ Res Public Health; 2017 Dec; 14(12):. PubMed ID: 29215581
    [No Abstract]   [Full Text] [Related]  

  • 55. Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza.
    Lu JY; Wilson J; Hou W; Fleysher R; Herold BC; Herold KC; Duong TQ
    EBioMedicine; 2023 Apr; 90():104487. PubMed ID: 36857969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stress-Induced and Diabetic Hyperglycemia Associated with Higher Mortality among Intensive Care Unit Trauma Patients: Cross-Sectional Analysis of the Propensity Score-Matched Population.
    Chang MW; Huang CY; Liu HT; Chen YC; Hsieh CH
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29762485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical characteristics and outcomes of COVID-19 infected diabetic patients admitted in ICUs of the southern region of Bangladesh.
    Saha A; Ahsan MM; Quader MT; Naher S; Akter F; Mehedi HMH; Ullah Chowdhury AA; Karim MH; Rahman T; Parvin A
    Diabetes Metab Syndr; 2021; 15(1):229-235. PubMed ID: 33445071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection.
    Laurenzi A; Caretto A; Molinari C; Mercalli A; Melzi R; Nano R; Tresoldi C; Rovere Querini P; Ciceri F; Lampasona V; Bosi E; Scavini M; Piemonti L
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1009-e1019. PubMed ID: 34718627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study.
    Tramunt B; Smati S; Coudol S; Wargny M; Pichelin M; Guyomarch B; Al-Salameh A; Amadou C; Barraud S; Bigot E; Bordier L; Borot S; Bourgeon M; Bourron O; Charrière S; Chevalier N; Cosson E; Fève B; Flaus-Furmaniuk A; Fontaine P; Galioot A; Gonfroy-Leymarie C; Guerci B; Lablanche S; Lalau JD; Larger E; Lasbleiz A; Laviolle B; Marre M; Munch M; Potier L; Prevost G; Renard E; Reznik Y; Seret-Bégué D; Sibilia P; Thuillier P; Vergès B; Gautier JF; Hadjadj S; Cariou B; Mauvais-Jarvis F; Gourdy P
    Eur J Endocrinol; 2021 Jul; 185(2):299-311. PubMed ID: 34085949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HbA1c measurement may save COVID-19 inpatients from overlooked diabetes.
    Yoroidaka A; Kurita S; Kita T
    J Diabetes Investig; 2022 Nov; 13(11):1925-1933. PubMed ID: 35704430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.